Clinical gene rearrangement studies in diffuse large B cell lymphoma (DLBCL) cases have shown that patients with DLBCL carry abundant MYC, BCL2, or BCL6 rearrangements (70). Here, BCL6 is linked to diffuse large B-cell lymphoma.